CAS NO: | 2375840-87-0 |
生物活性 | NDI-091143 is a potent and high-affinityhuman ATP-citrate lyase (ACLY)inhibitor with anIC50of 2.1 nM (ADP-Glo assay), aKiof 7.0 nM and aKdof 2.2 nM. NDI-091143 inhibitsACLYcatalysis allosterically, by stabilizing large conformational changes in the citrate domain that indirectly block the binding and recognition of citrate[1]. | ||||||||||||||||
IC50& Target | IC50: 2.1 nM (human ATP-citrate lyase); Ki: 7.0 nM (human ATP-citrate lyase); Kd: 2.2 nM (human ATP-citrate lyase)[1] | ||||||||||||||||
体外研究 (In Vitro) | Thermal shift assays shows that NDI-091143 gives rise to considerable stabilization of both full-length ACLY and the N-terminal segment. The thermal shift data are consistent with limited proteolysis experiments using full-length ACLY, in which NDI-091143 together with Mg-ATP provided the greatest protection against digestion by chymotrypsin[1]. | ||||||||||||||||
分子量 | 453.84 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H14ClF2NO5S | ||||||||||||||||
CAS 号 | 2375840-87-0 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(220.34 mM;ultrasonic and warming and heat to 60℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |